Literature DB >> 9245212

[Opioid intoxication. Inappropriate administration of transdermal fentanyl].

A Klockgether-Radke1, J Hildebrandt.   

Abstract

A 22-year-old male suffering from neuropathic pain in his right leg had sufficient analgesia with oral tilidin 300 mg per day. Nevertheless, the general practitioner decided to change the therapy to transdermal fentanyl. Having cut a fentanyl patch (50 micrograms/h) into pieces, he applied one-fourth of the patch; 60 min later the patient developed signs of opioid intoxication, including heavy sedation, nausea and respiratory depression. After the patch was removed another 60 min later, the patient made a complete recovery. The risks following inappropriate application of transdermal fentanyl are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9245212     DOI: 10.1007/s001010050420

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  7 in total

1.  Fatal outcome in a child after ingestion of a transdermal fentanyl patch.

Authors:  Jörg Teske; Jens-Peter Weller; Klaus Larsch; Hans Dieter Tröger; Matthias Karst
Journal:  Int J Legal Med       Date:  2006-11-18       Impact factor: 2.686

2.  [Accidental intoxication with unlabeled, generic transdermal fentanyl patches caused by insufficient instruction].

Authors:  S Tank; K Stork; W Skibba; S Zittel; H Andresen; A E Goetz; H Beck
Journal:  Anaesthesist       Date:  2007-11       Impact factor: 1.041

3.  [Transdermal intoxication through broken opioid ampules : Accidental intoxication in a paramedic].

Authors:  U Bartram; R Schmidt
Journal:  Anaesthesist       Date:  2020-01-30       Impact factor: 1.041

Review 4.  Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl.

Authors:  S Grond; L Radbruch; K A Lehmann
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

Review 5.  Transdermal fentanyl: pharmacology and toxicology.

Authors:  Lewis Nelson; Robert Schwaner
Journal:  J Med Toxicol       Date:  2009-12

Review 6.  Use of transdermal drug formulations in the elderly.

Authors:  Laure-Zoé Kaestli; Anne-Florence Wasilewski-Rasca; Pascal Bonnabry; Nicole Vogt-Ferrier
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 7.  Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain.

Authors:  Craig A Kornick; Juan Santiago-Palma; Natalia Moryl; Richard Payne; Eugenie A M T Obbens
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.